Keyphrases
Acute Coronary Syndrome
15%
African American
24%
AIDS/HIV
15%
Apolipoprotein E
13%
Ashkenazi
14%
Ashkenazi Jews
60%
Cardiovascular Disease
18%
Cell-free Fetal DNA
25%
Clinical Trials
15%
Confidence Interval
16%
Crohn's Disease
53%
Diabetes
32%
During Pregnancy
19%
Estrogen Receptor
15%
Estrogen Receptor 1 (ESR1)
21%
Estrogen Receptor Gene
16%
Fetal Cells
24%
Fetal DNA
14%
First Trimester
13%
Genetic Factors
16%
Genetic Risk
16%
Genetic Variants
26%
Genetic Variation
27%
Genome-wide Association Study
28%
Genotype
25%
Glucose-insulin-potassium
20%
Gut Microbiome
14%
Inflammatory Bowel Disease
67%
Intensive Lifestyle Intervention
16%
Jewish Population
28%
Leucine-rich Repeat Kinase 2 (LRRK2)
21%
Lifestyle Intervention
27%
Maternal Plasma
16%
Meta-analysis
31%
Microbiome
14%
Microbiota
19%
Multi-ethnic
15%
Myocardial Infarction
24%
Odds Ratio
15%
Parkinson's Disease
30%
People Living with HIV (PLHIV)
29%
Polygenic Risk Score
17%
Polymorphism
25%
Pregnant Women
24%
Risk Factors
16%
Single nucleotide Polymorphism
32%
Susceptibility Loci
14%
Type 2 Diabetes Mellitus (T2DM)
28%
United States
20%
Weight Loss
20%
Biochemistry, Genetics and Molecular Biology
Allele
61%
Apolipoprotein E
9%
Autophagy
11%
Blood Plasma
27%
Blood Pressure
10%
Body Height
12%
Candidate Gene
20%
Case-Control Study
10%
Clinical Trial
10%
Comorbidity
9%
CYP2C19
12%
CYP2C9
12%
CYP4F2
9%
Estrogen Receptor
23%
Exome Sequencing
14%
First Trimester Pregnancy
11%
Gene Expression
17%
Gene Frequency
9%
Gene Locus
13%
Genetic Determinism
26%
Genetic Divergence
70%
Genetic Risk
21%
Genetic Screening
13%
Genetic Variation
28%
Genetics
100%
Genome-Wide Association Study
37%
Genomics
28%
Genotyping
31%
Haplotype
42%
Human Immunodeficiency Virus
32%
Kinase
9%
Lipid
13%
Lipid Level
9%
Low-Density Lipoprotein
12%
LRRK2
17%
Microbiome
9%
Minor Allele Frequency
11%
Mouse Model
9%
NOD2
11%
Pharmacogenetics
12%
Phosphotransferase
9%
Polygenic Score
19%
Prevalence
13%
Real-Time Polymerase Chain Reaction
10%
Receptor Gene
16%
Second Trimester Pregnancy
15%
Single Nucleotide Polymorphism
13%
Single-Nucleotide Polymorphism
34%
Smoking
13%
VKORC1
13%
Medicine and Dentistry
Acute Coronary Syndrome
14%
Acute Intermittent Porphyria
8%
Allele
16%
Amnion Fluid
8%
Arm
7%
Bone Density
8%
Cardiometabolic Risk
8%
Cardiovascular Disease
13%
Cardiovascular System
9%
Cell-Free DNA
16%
Cell-Free Fetal DNA
16%
Clinical Trial
9%
Cohort Analysis
8%
Crohn's Disease
9%
Diabetes
31%
Disease
13%
Enteritis
9%
Faecal Calprotectin
8%
Fatty Acid
8%
First Trimester Pregnancy
15%
Gene Expression
17%
Genetic Screening
7%
Genetic Variation
16%
Genome Wide Association Study
8%
Globin Messenger RNA
7%
Glyceraldehyde 3 Phosphate Dehydrogenase
10%
Gut
11%
Gut Microbiome
8%
Human Immunodeficiency Virus
40%
Inflammatory Bowel Disease
17%
Inflammatory Bowel Disease
16%
Infusion
11%
Lifestyle Intervention
28%
Maternal Plasma
15%
Maternal Serum
7%
Maturity Onset Diabetes of the Young
24%
Messenger RNA
9%
Meta-Analysis
9%
Microbiome
13%
Myocardial Infarction
23%
Myocarditis
8%
Nucleic Acid
9%
Obesity
9%
Parkinson's Disease
9%
Prevalence
8%
Randomized Controlled Trial
8%
Second Trimester Pregnancy
10%
Single Nucleotide Polymorphism
16%
Ulcerative Colitis
7%
Venous Thromboembolism
8%
